Biofrontera Capex To Revenue from 2010 to 2024

BFRIW Stock  USD 0.13  0.05  64.77%   
Biofrontera Warrants Capex To Revenue yearly trend continues to be fairly stable with very little volatility. Capex To Revenue will likely drop to 0.0001 in 2024. Capex To Revenue is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. View All Fundamentals
 
Capex To Revenue  
First Reported
2010-12-31
Previous Quarter
0.00014675
Current Value
0.000139
Quarterly Volatility
0.00978414
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Biofrontera Warrants financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biofrontera Warrants' main balance sheet or income statement drivers, such as Tax Provision of 33 K, Interest Income of 90.6 K or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 0.12, Dividend Yield of 0.0 or PTB Ratio of 0.85. Biofrontera financial statements analysis is a perfect complement when working with Biofrontera Warrants Valuation or Volatility modules.
  
Check out the analysis of Biofrontera Warrants Correlation against competitors.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.

Latest Biofrontera Warrants' Capex To Revenue Growth Pattern

Below is the plot of the Capex To Revenue of Biofrontera Warrants over the last few years. It is the ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets. Biofrontera Warrants' Capex To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Biofrontera Warrants' overall financial position and show how it may be relating to other accounts over time.
Capex To Revenue10 Years Trend
Slightly volatile
   Capex To Revenue   
       Timeline  

Biofrontera Capex To Revenue Regression Statistics

Arithmetic Mean0.01
Geometric Mean0.01
Coefficient Of Variation70.55
Mean Deviation0.01
Median0.02
Standard Deviation0.01
Sample Variance0.000096
Range0.0204
R-Value(0.82)
Mean Square Error0.000034
R-Squared0.67
Significance0.0002
Slope(0)
Total Sum of Squares0

Biofrontera Capex To Revenue History

2024 1.39E-4
2023 1.47E-4
2022 0.001325
2020 4.56E-4

About Biofrontera Warrants Financial Statements

Biofrontera Warrants investors use historical fundamental indicators, such as Biofrontera Warrants' Capex To Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biofrontera Warrants. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.